Homozygous 11p15 P14 Deletion Syndrome C1847866
Homozygous 11p15 P14 deletion syndrome is a rare genetic condition involving loss of genetic material on chromosome 11. This deletion can affect growth and development. Care involves genetic counseling and supportive management of symptoms.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Hypoglycemia
Generalized symptoms
(congenital)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Growth retardation
(developmental)Developmental delay
(developmental)Distinctive facial features
(craniofacial)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive genetic syndrome management
Multidisciplinary surveillance program including regular abdominal ultrasound for tumor screening, growth monitoring, and endocrine evaluation. Early detection of associated features allows for timely intervention.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Growth hormone therapy
Individually assessed hormone replacement for patients with documented growth deficiency. Treatment requires endocrinology oversight with regular monitoring of IGF-1 levels and growth response.
Additional treatment options
Surgical intervention for tumor management
Prompt surgical resection of embryonal tumors such as hepatoblastoma or Wilms tumor when detected. Requires pediatric surgical expertise with careful perioperative planning.
surgicalDevelopmental support services
Early intervention programs providing speech, occupational, and physical therapy along with developmental pediatrics coordination to address learning and motor delays associated with the syndrome.
psychologicalNutritional support program
Individualized nutrition planning addressing feeding difficulties and hypoglycemia risk. May include specialized formulas or feeding assistance devices for infants with significant feeding challenges.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Homozygous 11p15 P14 Deletion Syndrome C1847866?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Homozygous 11p15 P14 Deletion Syndrome C1847866. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy